4D Molecular CEO Kirn sells 58,333 shares
4D Molecular Therapeutics Chief Executive Officer David Kirn sold 58,333 shares at $12.92 each, according to a Form 4 filing. The transaction was indicated as part of a 10b5-1 plan.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.